ReGen Biologics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2004
2005
2006
2007
2008
Net Income before Extraordinaries
6,781.00
11,731.00
12,657.00
10,377.00
9,951.00
Depreciation, Depletion & Amortization
53.00
40.00
65.00
90.00
102.00
Other Funds
378.00
661.00
1,218.00
1,461.00
2,153.00
Funds from Operations
6,350.00
11,030.00
11,374.00
8,826.00
7,696.00
Changes in Working Capital
238.00
1,307.00
865.00
332.00
921.00
Net Operating Cash Flow
6,112.00
9,723.00
12,239.00
9,158.00
6,775.00
Capital Expenditures
19.00
125.00
182.00
171.00
29.00
Purchase/Sale of Investments
-
3,995.00
3,347.00
548.00
100.00
Net Investing Cash Flow
19.00
4,120.00
3,165.00
377.00
71.00
Issuance/Reduction of Debt, Net
6.00
12.00
14.00
14.00
143.00
Net Financing Cash Flow
9,998.00
11,198.00
6,843.00
5,546.00
2,889.00
Net Change in Cash
3,867.00
2,655.00
2,267.00
3,260.00
3,758.00
Free Cash Flow
6,131.00
9,848.00
12,421.00
9,329.00
6,804.00
Change in Capital Stock
10,004.00
11,210.00
6,857.00
5,560.00
3,032.00
Exchange Rate Effect
-
10.00
36.00
25.00
57.00
Miscellaneous Funds
-
0.00
0.00
0.00
0.00
About ReGen Biologics
View Profile
